Patients with stage 4 chronic kidney disease (CKD) who were in the DAPA-CKD trial had…
View More Dapagliflozin Safe, Protective in Advanced Kidney Disease
Home »
FDA Panel Rejects Roxadustat for Anemia in Kidney Disease
An advisory committee to the US Food and Drug Administration (FDA) has overwhelmingly rejected the…
View More FDA Panel Rejects Roxadustat for Anemia in Kidney Disease
Race Coefficient Alters Kidney Disease Stage in Many Black Patients
The race coefficient routinely used in US practice for more than two decades to upwardly…
View More Race Coefficient Alters Kidney Disease Stage in Many Black Patients
Blood Test Predicts Organ Rejection Risk After Kidney Transplant
A functional immunologic assay that could easily be incorporated into routine laboratory work can predict…
View More Blood Test Predicts Organ Rejection Risk After Kidney Transplant